New Results

BRPF3 knockdown or inhibition moderately reverses olaparib resistance in high grade serous ovarian carcinoma, but depletion of H3K14 acetylation has no effect

Benjamin G. Bitler, Tomomi M. Yamamoto, Alexandra McMellen, Hyunmin Kim, Zachary L. Watson
doi: https://doi.org/10.1101/2021.12.21.473688

Article usage

Article usage: December 2021 to September 2023

AbstractFullPdf
Dec 2021559851
Jan 20224212281
Feb 2022541023
Mar 202235310
Apr 202241419
May 202223520
Jun 202225313
Jul 20222044
Aug 20221614
Sep 2022301016
Oct 2022351411
Nov 2022410247
Dec 202267725
Jan 202335912
Feb 202323521
Mar 202315316
Apr 202325019
May 202310110
Jun 20237116
Jul 202310416
Aug 20235118
Sep 2023816
Back to top
Posted December 22, 2021.
Download PDF

Supplementary Material

Email
BRPF3 knockdown or inhibition moderately reverses olaparib resistance in high grade serous ovarian carcinoma, but depletion of H3K14 acetylation has no effect
Benjamin G. Bitler, Tomomi M. Yamamoto, Alexandra McMellen, Hyunmin Kim, Zachary L. Watson
bioRxiv 2021.12.21.473688; doi: https://doi.org/10.1101/2021.12.21.473688
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area